Infectious Disorder clinical trials
10 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies
- Admission and Management of Occupational or Other Exposures to Biodefense/Bioterrorism Agents or to Epidemic/Emerging Infectious Diseases
- An International Observational Study of Adults With Acute Infection
- Biospecimen Analysis in Detecting Chemical Concentrations in Patients With Chronic or Infectious Diseases Receiving Meditations
- Triage Survey for Infectious Disease Eligibility
- AnovaOS Network Powered Patient Registry
- Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
- Collection and Distribution of Biospecimens for Novel Research Uses
- Compliant Analysis of Patient Samples and Data
- AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Infectious Disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.